About Helsinn
Helsinn is a company based in Lugano (Switzerland) founded in 1976 by Gabriele Braglia.. The company has 103 employees as of December 31, 2021. Helsinn has completed 1 acquisition, including Sapphire Therapeutics. Helsinn offers products and services including AKYNZEO® and ALOXI®. Helsinn operates in a competitive market with competitors including Aster Insights, Abogen Biosciences, OnCusp, CancerVax and Linical, among others.
- Headquarter Lugano, Switzerland
- Employees 103 as on 31 Dec, 2021
- Founders Gabriele Braglia
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Helsinn Therapeutics U.S., Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
103
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Helsinn
Helsinn offers a comprehensive portfolio of products and services, including AKYNZEO® and ALOXI®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medication for preventing chemotherapy-induced nausea
Treatment for nausea and vomiting in cancer therapy
Unlock access to complete
Sales and Marketing
14 people
Software Development Team
8 people
Product Management Team
3 people
Leadership Team
3 people
Human Resources and Administration
3 people
Strategic Team
1 people
Environment Team
1 people
Legal and Compliance
1 people
Unlock access to complete
Funding Insights of Helsinn
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Private Equity Round - Helsinn | Valuation | Oberland Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Helsinn
Helsinn has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Oberland Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Helsinn
Helsinn has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sapphire Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule drugs are developed for metabolic and oncologic disorders.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Helsinn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Helsinn Comparisons
Competitors of Helsinn
Helsinn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aster Insights, Abogen Biosciences, OnCusp, CancerVax and Linical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
CRO offering clinical development services for oncology drugs
|
|
| domain | founded_year | HQ Location |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| domain | founded_year | HQ Location |
Full-service CRO operations are conducted across more than 20 countries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Helsinn
Frequently Asked Questions about Helsinn
When was Helsinn founded?
Helsinn was founded in 1976 and raised its 1st funding round 47 years after it was founded.
Where is Helsinn located?
Helsinn is headquartered in Lugano, Switzerland. It is registered at Lugano, Ticino, Switzerland.
How many employees does Helsinn have?
As of Dec 31, 2021, the latest employee count at Helsinn is 103.
What does Helsinn do?
CDMO focused on developing, manufacturing, and commercialising oncology therapeutics. The company recognized for its leadership in cancer supportive care, particularly in managing side effects of cancer therapies such as chemotherapy-induced nausea and vomiting. It portfolio extends to products that improve the quality of life for patients with chronic diseases.
Who are the top competitors of Helsinn?
What products or services does Helsinn offer?
Helsinn offers AKYNZEO® and ALOXI®.
How many acquisitions has Helsinn made?
Helsinn has made 1 acquisition, including Sapphire Therapeutics.
Who are Helsinn's investors?
Helsinn has 1 investor. Key investors include Oberland Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.